IP Library Granted Patent US 11,975,054
Granted Patent B2
US 11,975,054 · App. 16/816,097 · Granted May 7, 2024

Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same

Inventor: Wayne K. Herber (Coopersburg, PA)
Assignee: ENDO GLOBAL VENTURES
A61K38/4886C12N9/50C12N9/52C12Q1/37C12Y304/24003G01N33/5044G01N33/56911G01N2333/96419Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,975,054
App. No.
16/816,097
Granted
May 7, 2024
Kind
B2
Abstract

The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.

Claims (12)

1. A recombinant nucleic acid molecule, comprising:

a polynucleotide encoding the amino acid sequence of SEQ ID NO: 5; and

a heterologous regulatory sequence operably linked to the polynucleotide.

2. The recombinant nucleic acid molecule of claim 1 , wherein the heterologous regulatory sequence is a promoter.

3. The recombinant nucleic acid molecule of claim 1 , wherein the recombinant nucleic acid molecule is fused to a marker sequence.

4. The recombinant nucleic acid molecule of claim 3 , wherein the marker sequence encodes a polypeptide selected from a glutathione-S-transferase (GST) fusion protein, a hemagglutinin A (HA) polypeptide from influenza, and a hexa-histidine peptide.

5. A vector comprising the recombinant nucleic acid molecule of claim 1 .

6. The vector of claim 5 , wherein the vector is a plasmid.

7. A recombinant host cell comprising the vector of claim 5 .

8. The recombinant host cell of claim 7 , wherein the host cell is selected from a bacterial cell, a fungal cell, an insect cell, a plant cell, and a mammalian cell.

9. The recombinant host cell of claim 8 , wherein the host cell is E. coli , a Streptomyces species, a Pseudomonas species, Serratia marcescens, Salmonella typhimurium , a yeast cell, a plant cell, a thymocyte, a Chinese hamster ovary cell (CHO), a COS cell, or Lactococcus lactis.

10. A method of producing collagenase I, the method comprising culturing the recombinant host cell of claim 7 under conditions suitable for expression of the polynucleotide and recovering the collagenase I.

Assignments (12)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE PREVIOUSLY LISTED APPLICATION NUMBERS 10603365 AND 11879141 PREVIOUSLY RECORDED AT REEL: 67199 FRAME: 31. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 10, 2024
From: ENDO GLOBAL VENTURES
To: PALADIN PHARMA INC.
Reel/Frame 067622/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0736 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067221/0970 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067216/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ENDO GLOBAL VENTURES
To: PALADIN PHARMA INC.
Reel/Frame 067199/0031 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0170 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: HERBER, WAYNE K.
To: AUXILIUM PHARMACEUTICALS, INC.
Reel/Frame 052381/0421 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: AUXILIUM PHARMACEUTICALS, INC.
To: AUXILIUM BERMUDA UNLIMITED
Reel/Frame 052381/0563 →
CHANGE OF NAME Recorded Apr 13, 2020
From: AUXILIUM BERMUDA UNLIMITED
To: ENDO GLOBAL VENTURES
Reel/Frame 052385/0036 →
Continuity (5)
Continuation 15669286 · Aug 4, 2017
Division 14328772 · Jul 11, 2014
Continuation PCTUS2013020940 · Jan 10, 2013
Provisional Application 61585909 · Jan 12, 2012
Related Publication 20200206326A1 · Jul 2, 2020